Intuitive Surgical (NASDAQ:ISRG) was upgraded by stock analysts at Oppenheimer from an “underperform” rating to a “market perform” rating in a research report issued on Wednesday, Briefing.com reports.
Several other equities research analysts have also recently weighed in on the company. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell assumed coverage on Intuitive Surgical in a report on Thursday, April 1st. They issued a “buy” rating and a $862.00 target price for the company. JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $825.00 to $840.00 and gave the stock an “overweight” rating in a report on Friday, January 22nd. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $804.00 price objective for the company in a research note on Tuesday, April 6th. Wells Fargo & Company upped their price objective on Intuitive Surgical from $841.00 to $879.00 and gave the stock an “overweight” rating in a research note on Friday, January 22nd. Finally, Raymond James upped their price objective on Intuitive Surgical from $800.00 to $865.00 and gave the stock an “outperform” rating in a research note on Friday, January 22nd. Eight analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $765.58.
ISRG stock opened at $811.11 on Wednesday. Intuitive Surgical has a twelve month low of $488.00 and a twelve month high of $826.81. The business’s 50-day moving average price is $743.58 and its 200-day moving average price is $754.63. The stock has a market cap of $96.02 billion, a P/E ratio of 92.38, a PEG ratio of 8.96 and a beta of 0.98.
In related news, SVP Jamie Samath sold 215 shares of the stock in a transaction on Tuesday, March 2nd. The stock was sold at an average price of $760.00, for a total value of $163,400.00. Following the transaction, the senior vice president now directly owns 672 shares of the company’s stock, valued at approximately $510,720. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Curet Myriam sold 379 shares of the stock in a transaction on Tuesday, March 2nd. The stock was sold at an average price of $760.00, for a total value of $288,040.00. Following the completion of the transaction, the executive vice president now directly owns 846 shares in the company, valued at $642,960. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,108 shares of company stock worth $22,162,955. 1.60% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Bank of New York Mellon Corp raised its stake in Intuitive Surgical by 2.5% during the fourth quarter. Bank of New York Mellon Corp now owns 3,073,903 shares of the medical equipment provider’s stock worth $2,514,761,000 after acquiring an additional 75,436 shares during the period. Baillie Gifford & Co. raised its stake in Intuitive Surgical by 1.8% during the fourth quarter. Baillie Gifford & Co. now owns 1,910,477 shares of the medical equipment provider’s stock worth $1,562,961,000 after acquiring an additional 33,415 shares during the period. Fisher Asset Management LLC increased its stake in shares of Intuitive Surgical by 5.1% in the fourth quarter. Fisher Asset Management LLC now owns 1,223,409 shares of the medical equipment provider’s stock valued at $1,000,871,000 after purchasing an additional 59,918 shares during the period. Norges Bank acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $852,020,000. Finally, Jennison Associates LLC boosted its holdings in shares of Intuitive Surgical by 8.7% in the fourth quarter. Jennison Associates LLC now owns 973,997 shares of the medical equipment provider’s stock valued at $796,827,000 after acquiring an additional 77,641 shares in the last quarter. Hedge funds and other institutional investors own 86.50% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Recommended Story: What are the Benefits of Index Funds?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.